• News
  • BioTech

Allergan to cut about 1,500 jobs to evade Valeant takeover

Allergan Inc., the drugmaker fending off a takeover by Valeant Pharmaceuticals International Inc., will cut 1,500 jobs and may use the savings for an acquisition, its chief executive officer said.

To continue reading, subscribe now
log in to your account
User Response
0 UserComments
Subscribe Today!